Economic Evaluation of Letrozole for Early Breast Cancer in a Health Resource-Limited Setting

Figure 4

Cost-effectiveness acceptability curves of AI 5-year strategy and AI switch strategy in comparison with tamoxifen strategy. The y-axis indicates the probability that a strategy is cost-effective across the willingness to pay per QALY gained (x-axis). The vertical dashed line represents the thresholds for China.